Published in Women's Health Weekly, November 19th, 2009
"We are very excited to have Dr. Goldstein on the medical advisory board as we are advancing Menerba™ to Phase 3," said Mary Tagliaferri, M.D., L.Ac., Bionovo's President and Chief Medical Officer. She added, "Given the concern from the FDA regarding uterine safety in postmenopausal trials using traditional estrogen therapy, his groundbreaking work...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly